Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.

Pathology international - 1 Sept 2022

Teruyama Fumiya, Kuno Akihiro, Murata Yoshihiko, Nakagawa Tomoki, Shiba-Ishii Aya, Yuguchi Shu, Noguchi Masayuki

Abstract excerpt

Angiosarcoma is a rare malignant tumor derived from vascular endothelial cells and has a poor prognosis. We have experienced a case of multiple breast angiosarcoma for which multiple resections had been performed during the course of its progression over a period of more than 15 years, allowing comprehensive genetic mutation analysis. Somatic mutations in several cancer-related genes were detected, but no...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Endothelial Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemangiosarcoma

Share to Mutation

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Tumor Suppressor Protein p53

Share to Vascular Endothelial Growth Factor Receptor-2

Source

Identifiers

PMID: 35801418
DOI: 10.1111/pin.13257

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.PMID 35801418Read ↗

Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.Semantic proximity Read ↗

Clinicopathologic and Molecular Analysis of Primary Angiosarcoma of Bone-A Single Institution Experience.Semantic proximity Read ↗

Breast Angiosarcoma: a SEER Population- Based StudySemantic proximity Read ↗

Recurrent PTPRB and PLCG1 mutations in angiosarcoma.Semantic proximity Read ↗

Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.Semantic proximity Read ↗

Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.Semantic proximity Read ↗

Clinicopathological features, treatment outcomes, and prognostic factors of angiosarcoma: a 21-year experience at one centerSemantic proximity Read ↗

Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human AngiosarcomaSemantic proximity Read ↗

Genomic analysis reveals shared genes and pathways in human and canine angiosarcomaSemantic proximity Read ↗

Post-irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review.Semantic proximity Read ↗

Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report.Semantic proximity Read ↗

Cutaneous angiosarcoma: a current update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.